Opposing unfolded-protein-response signals converge on death receptor 5 to control apoptosis

See allHide authors and affiliations

Science  04 Jul 2014:
Vol. 345, Issue 6192, pp. 98-101
DOI: 10.1126/science.1254312

Life and death and quality control

When cells are subjected to too much stress, they curl up their toes and die. Lu et al. describe a clever strategy cells use to stay alive as long as they are not stressed for too long. The cells' quality-control machinery will activate a so-called death receptor when defective proteins accumulate within the cell, a sign of stress—but they will wait until the proteins have built up for a good long time. If stress is relieved soon enough, levels of the death receptor decay back to normal, and the cells stay alive; otherwise, R.I.P.

Science, this issue p. 98


Protein folding by the endoplasmic reticulum (ER) is physiologically critical; its disruption causes ER stress and augments disease. ER stress activates the unfolded protein response (UPR) to restore homeostasis. If stress persists, the UPR induces apoptotic cell death, but the mechanisms remain elusive. Here, we report that unmitigated ER stress promoted apoptosis through cell-autonomous, UPR-controlled activation of death receptor 5 (DR5). ER stressors induced DR5 transcription via the UPR mediator CHOP; however, the UPR sensor IRE1α transiently catalyzed DR5 mRNA decay, which allowed time for adaptation. Persistent ER stress built up intracellular DR5 protein, driving ligand-independent DR5 activation and apoptosis engagement via caspase-8. Thus, DR5 integrates opposing UPR signals to couple ER stress and apoptotic cell fate.

The endoplasmic reticulum (ER) mediates folding and maturation of transmembrane and secreted proteins (1, 2). Elevated physiological demand for protein folding can cause misfolded proteins to accumulate in the ER lumen—a condition called ER stress. The unfolded protein response (UPR) senses such stress and mediates cellular adaptation by expanding the ER’s protein-folding capacity while decreasing its synthetic load. Protein kinase R (PKR)–like kinase (PERK) and inositol-requiring enzyme 1α (IRE1α) are two key metazoan UPR sensors (1, 2); residing in the ER membrane, each has a lumenal domain that detects misfolded polypeptides. PERK harbors a cytoplasmic kinase moiety that phosphorylates eukaryotic translation-initiation factor 2α (eIF2α). This suppresses general translation but promotes synthesis of preferred factors—including ATF4, which activates the UPR transcription factor CCAAT/enhancer-binding protein homologous protein (CHOP), among other genes. IRE1α has both kinase and endoribonuclease (RNase) cytoplasmic moieties (3). The kinase controls RNase activity, which mediates regulated IRE1α-dependent decay (RIDD) of ER-associated mRNAs (4) and generates the UPR transcription factor X-box binding protein 1 spliced (XBP1s). Certain pathological conditions can cause irresolvable ER stress (5), often leading to apoptotic cell death (1, 2, 6). Two interconnected signaling cascades control apoptosis: the intrinsic, mitochondrial pathway, and the extrinsic, death-receptor pathway (7). Each engages distinct proteases, called initiator caspases, to activate a common set of executioner caspases (8). Unmitigated ER stress regulates the intrinsic pathway via several Bcl-2 family proteins (1, 2, 6, 9, 10). Furthermore, IRE1α cleaves specific micro-RNAs to derepress caspase-2 expression (11); however, caspase-2 may be dispensable for ER stress-induced apoptosis (12), which leaves the underlying initiation mechanisms obscure.

Experiments with biological and pharmacological ER stressors revealed consistent activation of caspase-8, the pivotal initiator in the extrinsic pathway (8) (Fig. 1). The bacterial AB5 subtilase cytotoxin SubAB induces pathophysiological ER stress by cleaving the chaperone BiP (13). SubAB caused dose-dependent BiP depletion and ER stress, evident by CHOP and XBP1s up-regulation, in KMS11 multiple myeloma cells (Fig. 1A). In keeping with data that PERK activity persists, whereas IRE1α activation is transient (14), CHOP remained elevated, whereas XBP1s declined by 24 hours. SubAB also induced activation of caspase-8 and caspase-3 by 24 hours, evident by cleaved caspase and poly(ADP ribose) polymerase (PARP) products. SubAB substantially increased caspase-8 and caspase-3/7 enzymatic activity, and DNA fragmentation—an apoptotic hallmark (fig. S1, A to C). Brefeldin-A (BfA)—an inhibitor of ER-to-Golgi trafficking—similarly induced ER stress, caspase activation, and apoptosis in SK-MES-1 lung carcinoma cells (Fig. 1B and fig. S1, D to F). The sarcoplasmic ER calcium–adenosine triphosphatase inhibitor thapsigargin (Tg) induced persistent CHOP and transient XBP1s expression in wild-type and in Bax−/− HCT116 colon carcinoma cells; whereas apoptosis required Bax, caspase-8 activation did not (Fig. 1, C and D, and fig. S1, G to I). Moreover, small interfering RNA (siRNA) depletion of caspase-8, but not caspase-2, blocked activation of caspase-3/7 and apoptosis by diverse ER stressors (Fig. 1, E and F, and fig. S1, J to O). Caspase-8 activates the Bcl-2 family protein Bid to engage the intrinsic pathway via Bax (15, 16). Full-length Bid declined in association with Tg-induced caspase-8 activation (fig. S1I), which indicated Bid processing. Bid siRNA knockdown commensurately attenuated Tg-induced apoptosis, whereas caspase-8 siRNA inhibited both Bid processing and apoptosis (fig. S1, P to S). Tg also up-regulated Bim (fig. S1I) as reported (10); however, caspase-8 and Bid processing occurred much earlier, which suggests that Bim might support later apoptotic signals. Thus, caspase-8 plays a pivotal role, whereas caspase-2 appears dispensable, during apoptosis induction by unmitigated ER stress.

Fig. 1 Unmitigated ER stress triggers apoptosis via caspase-8.

(A) KMS11 cells were treated with SubAB and analyzed by immunoblot. cC8: cleaved caspase-8; cC3: cleaved caspase-3. (B) SK-MES-1 cells were treated with BfA (24 hours) and analyzed by immunoblot. (C and D) Wild-type (WT) or Bax−/− HCT116 cells were treated with Tg (100 nM) and analyzed by immunoblot (C), or caspase-8 activity assay (24 hours) (D). (E and F) HCT116 cells were transfected (48 hours) with control siRNA (Cont), a single (C8a), or an independent pool (C8b) of caspase-8 siRNAs, or caspase-2 siRNA. Cells were treated with Tg (100 nM, 24 hours) and analyzed by immunoblot (E) or FACS to measure apoptosis by subG1 DNA content (F). Graphs depict means ± SD of triplicates (D) or duplicates (F).

Upon binding of cognate extracellular ligands, the death receptors Fas, DR4, or DR5 nucleate a death-inducing signaling complex (DISC) at the plasma membrane, which activates caspase-8 via the adaptor Fas-associated death domain (FADD) (17). Consistent with evidence that ER stress up-regulates DR5 transcription (18), quantitative reverse transcription polymerase chain reaction (QPCR) showed a two- to fourfold DR5 mRNA induction by Tg, BfA, SubAB, or the glycosylation inhibitor tunicamycin (Tm), with less impact on DR4, Fas, or TNFR1 (Fig. 2, A and B, and fig. S2, A to C). ER stressors most often elevated both the long (DR5L) and short (DR5S) splice variants of DR5 (Fig. 2C and fig. S2, D to H) (19). Tg up-regulated DR5 within 6 hours, in concert with CHOP and XBP1s induction, yet preceding caspase-8 processing (Fig. 2C and fig. S2D). Furthermore, Tg induced a DR5-nucleated complex with FADD and caspase-8, harboring elevated caspase-8 activity, independent of Bax (Fig. 2D and fig. S2, I to K). Immunoprecipitation (IP) of DR5 or caspase-8 showed comparable caspase-8 activity (fig. S2L). Consistently, other ER stressors increased DR5-associated caspase-8 activity in multiple cell lines (fig. S2, M to O). Livers from Tm-treated mice also showed elevated DR5 and cleaved caspase-8 in conjunction with apoptosis (fig. S2, P and Q). DR5 siRNA knockdown in different cell lines strongly inhibited caspase activation and apoptosis in response to various ER stressors (Fig. 2, E to H, and fig. S2, R to X). Thus, DR5 is critical for caspase-8–mediated apoptotic engagement by unmitigated ER stress.

Fig. 2 Unmitigated ER stress activates caspase-8 via DR5.

(A) HCT116 cells were treated with Tg (100 nM), and mRNA levels were measured by QPCR [normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH)]. (B) HCT116 cells were treated with Tm (1 μg/ml), Tg (100 nM), BfA (1 μg/ml), or SubAB (1 μg/ml) and analyzed by QPCR (normalized to GAPDH). (C) HCT116 cells were treated with Tg (100 nM) and analyzed by immunoblot. (D) WT or Bax−/− HCT116 cells were treated as in (C) (24 hours), subjected to DR5 IP, and analyzed by immunoblot. (E to H) HCT116 cells were transfected (48 hours) with control siRNA (Cont), a single (DR5a), or an independent pool (DR5b) of DR5 siRNAs; then treated with Tg (100 nM, 24 hours) and analyzed by immunoblot (E), by enzymatic activity assay for caspase-8 (F) or caspase-3/7 (G), or by FACS for apoptosis (H). Graphs depict means ± SD of triplicates.

Remarkably, siRNA depletion of the sole DR5 ligand, Apo2L/TRAIL (apo2 ligand/tumor necrosis factor–related apoptosis-inducing ligand), had no impact on Tg-induced apoptosis in HCT116 or SK-MES-1 cells, unlike caspase-8 knockdown (Fig. 3A and fig. S3, A and B). Moreover, neutralization of extracellular Apo2L/TRAIL by using soluble DR4- and DR5-Fc fusion proteins, which blocked exogenously added ligand, did not inhibit apoptosis activation by Tg or BfA (Fig. 3B and fig. S3, C and D). Thus, ER stress induces ligand-independent DR5 activation. DR5 was barely detectable by immunofluorescence in resting SK-MES-1 cells but showed higher abundance with the addition of Tg or BfA (Fig. 3C). In Tg-treated cells, DR5 colocalized with the Golgi marker RACS1 but not the ER marker KDEL; however, in BfA-treated cells—which had minimal Golgi—DR5 did colocalize with KDEL (Fig. 3D and fig. S3, E and F). Despite massively elevating total DR5, BfA did not substantially up-regulate cell surface DR5, nor did it increase sensitivity to exogenous Apo2L/TRAIL (fig. S3, G to J). However, Tg, which up-regulated both total and cell surface DR5, did enhance sensitivity to added ligand (fig. S3, K to N). DR5 partially colocalized with cleaved caspase-8 within Tg-treated cells (fig. S3O), which supports intracellular activation. Size-exclusion chromatography of detergent extracts from HCT116 cells revealed Tg-driven up-regulation of DR5L and DR5S in low molecular weight (MW) fractions—representing DR5 oligomers; elevated DR5L appeared also in high MW fractions—which indicates the presence of DR5L multimers (Fig. 3E). Caspase-8 activity occurred in two peaks: one coinciding with DR5L in high MW fractions, the other separate from DR5 in low MW compartments (Fig. 3F). Chemical cross-linking verified Tg-induced formation of DR5 oligomers and multimers (fig. S3P). Furthermore, selective DR5L siRNA knockdown attenuated Tg-driven activation of caspase-8 and apoptosis (fig. S3, Q to T). Thus, Tg up-regulates both DR5 variants but DR5L preferentially multimerizes, recruiting and activating caspase-8 and releasing processed enzyme into lower MW fractions.

Fig. 3 Unmitigated ER stress engages caspase-8 by inducing ligand-independent intracellular DR5 activation.

(A) HCT116 cells were transfected (48 hours) with control siRNA or siRNA targeting Apo2L/TRAIL or caspase-8. Cells were treated with Tg (100 nM, 24 hours) and analyzed for apoptosis. (B) HCT116 cells were treated (24 hours) with Apo2L/TRAIL (1 μg/ml) or Tg (100 nM) in the presence of vehicle or DR4-Fc plus DR5-Fc (10 μg/ml each) and analyzed for apoptosis. (C) SK-MES-1 cells were treated (16 hours) with indicated ER stressors and analyzed by immunofluorescence with DR5-specific antibody. (D) SK-MES-1 cells were treated with Tg (20 nM, 24 hours) and analyzed by immunofluorescence for DR5 or RACS1. (E and F) HCT116 cells were treated with Tg (100 nM, 24 hours), extracted with 1% Triton X-100, and subjected to size-exclusion chromatography; fractions were analyzed by DR5 IP and immunoblot (E) or caspase-8 activity assay (F). Control: direct DR5 IP from Tg-treated cells. Graphs depict means ± SD of duplicates (B) or triplicates (F). Scale bars: 20 μm (C and D).

Consistent with earlier evidence (18, 20), siRNA depletion of CHOP substantially blocked DR5 mRNA up-regulation by Tg or BfA, whereas knockdown of the CHOP transcriptional targets ER oxidase 1α (ERO1α) or growth arrest and DNA damage–inducible 34 (GADD34) did not (Fig. 4A and fig. S4, A to E); these findings support direct CHOP control of DR5 mRNA. Although GADD34 dephosphorylates eIF2α to reinitiate translation, ERO1α is important for protein disulfide isomerization and folding in the ER lumen (6). ERO1α knockdown did inhibit DR5L protein up-regulation and the associated apoptotic events (fig. S4, F to H), which suggests that ERO1α may facilitate folding of DR5L (DR5L harbors more cysteine residues than DR5S). In contrast to CHOP depletion, siRNA knockdown of IRE1α attenuated DR5 mRNA decay in Tg-treated cells (Fig. 4B and fig. S4, I to L), which suggests that IRE1α counteracts apoptosis by mediating DR5 RIDD. Indeed, a recombinant protein comprising IRE1α’s catalytic domains cleaved in vitro transcribed DR5 mRNAs at discrete sites, and this was blocked by the IRE1α RNase inhibitor 4μ8C (21) (Fig. 4C and fig. S4M). Furthermore, whereas CHOP siRNA attenuated Tg-induced DR5 up-regulation, caspase-8 activation, and apoptosis, IRE1α depletion augmented these events (Fig. 4, D and E, and fig. S4N). Conversely, XBP1s knockdown—which led to compensatory IRE1α hyperphosphorylation (Fig. 4D) as reported (22)—accelerated DR5 mRNA decay and diminished DR5 up-regulation, caspase-8 activation, and apoptosis (Fig. 4, B, D, and E, and fig. S4, J to L and N). Finally, 4μ8C enhanced caspase activation by Tg (Fig. 4F and fig. S4O), which confirms an antiapoptotic role for IRE1α RNase. Thus, CHOP and RIDD exert opposing effects on DR5 to control caspase-8 activation and apoptosis.

Fig. 4 DR5 integrates opposing UPR signals to control apoptosis.

(A) HCT116 cells were transfected (48 hours) with control or CHOP siRNA, treated with Tg (8 hours), and analyzed by QPCR (normalized to GAPDH). (B) HCT116 cells were transfected (48 hours) with control, IRE1α, or XBP1 siRNA; and treated with actinomycin D (2 μg/ml) plus Tg (20 nM), then DR5 mRNA was measured as in (A). (C) Purified recombinant human IRE1α comprising the kinase and RNase domains (KR43) was incubated with in vitro transcribed DR5L or DR5S mRNA in the presence of vehicle or 4μ8C (10 μM). Reactions were resolved on a 6% Tris-borate-EDTA (TBE)-urea polyacrylamide electrophoresis gel and stained with SYBR Gold. (D and E) HCT116 cells were transfected (48 hours) with control, IRE1α, CHOP, or XBP1 siRNA; treated with Tg (100 nM, 24 hours); and analyzed by immunoblot (D) or caspase-8 activity assay (E). (F) HCT116 cells were treated with Tg (100 nM, 24 hours) in the presence of vehicle or 4μ8C (30 μM) and analyzed for caspase-8 activity. Graphs depict means ± SD of triplicates.

Our data delineate a cell-autonomous mechanism wherein DR5 integrates dynamic UPR signals to control apoptosis in relation to ER stress (fig. S4P). Upon reversible ER disruption, PERK-CHOP activity induces, whereas RIDD suppresses, DR5 transcripts. If ER stress resolves, UPR activity subsides, and DR5 mRNA returns to baseline. However, if ER stress prevails, PERK-CHOP function persists, whereas IRE1α activity attenuates (14), which permits DR5 mRNA to rise. DR5 accumulation in the ER and Golgi apparatus drives ligand-independent multimerization of DR5L, which—consistent with earlier data (23)—has greater propensity to cluster than DR5S. ERO1α, previously implicated in UPR-driven apoptosis (6), facilitates DR5L up-regulation, perhaps by supporting disulfide isomerization. DR5L provides a DISC-like intracellular platform for caspase-8 recruitment and apoptosis initiation. It was proposed that ER stress augments apoptosis by increasing autocrine death-ligand signaling (18, 24, 25); however, ER disruption would attenuate ligand secretion. Our data reveal that DR5 acts as an intracellular “gauge” for persistence of ER stress. Opposing controls on DR5 mRNA synthesis and decay by PERK-CHOP versus IRE1α define a time window for adaptation, before committing the cell to an apoptotic fate.

Supplementary Materials

Materials and Methods

Figs. S1 to S4

References (2630)

References and Notes

  1. ACKNOWLEDGMENTS: We thank R. Pitti and Genentech’s peptide, DNA and chemical synthesis, and fluorescence-activated cell sorting (FACS) laboratories for assistance.
View Abstract

Navigate This Article